Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Issues relating to pharmacy benefit managers;; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act; H.R.4317 PBM Reform Act of 2025
Issues relating to pharmacy benefit managers;; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act; H.R.4317 PBM Reform Act of 2025
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
LEXINGTON LAW via EMERGENT STRATEGIES
2026 · third_quarter · Q3
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act S.4144, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
Issues relating to pharmacy benefit managers;; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act; H.R.4317 PBM Reform Act of 2025
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act S.4144, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act S.4144, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act S.4144, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act S.4144, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act S.4144, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act S.4144, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act S.4144, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
Issues related to competition in mobile app ecosystems; S.__ American Innovation and Choice Online Act; S.2153 Open App Markets Act; H.R.3209 App Store Freedom Act
Issues related to competition in mobile app ecosystems; S.4746 American Innovation and Choice Online Act; S.2513 Open App Markets Act; H.R.3209 App Store Freedom Act; H.R.8413 SECURE Data Act.
Issues related to competition in mobile app ecosystems; S.__ American Innovation and Choice Online Act; S.2153 Open App Markets Act; H.R.3209 App Store Freedom Act
Issues related to competition in mobile app ecosystems; S.4746 American Innovation and Choice Online Act; S.2513 Open App Markets Act; H.R.3209 App Store Freedom Act
Issues related to competition in mobile app ecosystems; S.4746, American Innovation and Choice Online Act; S.2153, Open App Markets Act; H.R.3209, App Store Freedom Act; H.R.8413, SECURE Data Act
Issues related to competition in mobile app ecosystems; S.4746, American Innovation and Choice Online Act; S.2153, Open App Markets Act; H.R.3209, App Store Freedom Act
Issues related to competition in mobile app ecosystems; S.__ American Innovation and Choice Online Act; S.2153 Open App Markets Act; H.R.3209 App Store Freedom Act
Issues related to competition in mobile app ecosystems; S.__ American Innovation and Choice Online Act; S.2153 Open App Markets Act; H.R.3209 App Store Freedom Act
PBM Reform Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues relating to pharmacy benefit managers;; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act; H.R.4317 PBM Reform Act of 2025
PBM Reform Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues relating to pharmacy benefit managers;; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act; H.R.4317 PBM Reform Act of 2025
PBM Reform Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues relating to pharmacy benefit managers;; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act; H.R.4317 PBM Reform Act of 2025
Issues related to competition in mobile app ecosystems; S.4746 American Innovation and Choice Online Act; S.2513 Open App Markets Act; H.R.3209 App Store Freedom Act; H.R.8413 SECURE Data Act.
Issues related to competition in mobile app ecosystems; S.4746, American Innovation and Choice Online Act; S.2153, Open App Markets Act; H.R.3209, App Store Freedom Act; H.R.8413, SECURE Data Act
PROTECT Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues relating to pharmacy benefit managers;; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act; H.R.4317 PBM Reform Act of 2025
PROTECT Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues relating to pharmacy benefit managers;; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act; H.R.4317 PBM Reform Act of 2025
PROTECT Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues relating to pharmacy benefit managers;; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act; H.R.4317 PBM Reform Act of 2025
Issues related to competition in mobile app ecosystems; S.__ American Innovation and Choice Online Act; S.2153 Open App Markets Act; H.R.3209 App Store Freedom Act
Issues related to competition in mobile app ecosystems; S.__ American Innovation and Choice Online Act; S.2153 Open App Markets Act; H.R.3209 App Store Freedom Act
Issues related to competition in mobile app ecosystems; S.__ American Innovation and Choice Online Act; S.2153 Open App Markets Act; H.R.3209 App Store Freedom Act
Issues related to competition in mobile app ecosystems; S.4746, American Innovation and Choice Online Act; S.2153, Open App Markets Act; H.R.3209, App Store Freedom Act
Issues related to competition in mobile app ecosystems; S.4746, American Innovation and Choice Online Act; S.2153, Open App Markets Act; H.R.3209, App Store Freedom Act; H.R.8413, SECURE Data Act
Issues related to competition in mobile app ecosystems; S.__ American Innovation and Choice Online Act; S.2153 Open App Markets Act; H.R.3209 App Store Freedom Act
Issues related to competition in mobile app ecosystems; S.4746 American Innovation and Choice Online Act; S.2513 Open App Markets Act; H.R.3209 App Store Freedom Act
Issues related to competition in mobile app ecosystems; S.4746 American Innovation and Choice Online Act; S.2513 Open App Markets Act; H.R.3209 App Store Freedom Act; H.R.8413 SECURE Data Act.
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act S.4144, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act S.4144, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act S.4144, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act S.4144, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act S.4144, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act S.4144, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act S.4144, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
Issues related to competition in mobile app ecosystems; S.4746, American Innovation and Choice Online Act; S.2153, Open App Markets Act; H.R.3209, App Store Freedom Act; H.R.8413, SECURE Data Act
Issues related to competition in mobile app ecosystems; S.4746, American Innovation and Choice Online Act; S.2153, Open App Markets Act; H.R.3209, App Store Freedom Act
Issues related to competition in mobile app ecosystems; S.4746 American Innovation and Choice Online Act; S.2513 Open App Markets Act; H.R.3209 App Store Freedom Act
Issues related to competition in mobile app ecosystems; S.4746 American Innovation and Choice Online Act; S.2513 Open App Markets Act; H.R.3209 App Store Freedom Act; H.R.8413 SECURE Data Act.
Issues relating to pharmacy benefit managers;; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act; H.R.4317 PBM Reform Act of 2025
Issues relating to pharmacy benefit managers;; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act; H.R.4317 PBM Reform Act of 2025
Issues relating to pharmacy benefit managers;; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act; H.R.4317 PBM Reform Act of 2025
Protecting Pharmacies in Medicaid Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues relating to pharmacy benefit managers;; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act; H.R.4317 PBM Reform Act of 2025
Protecting Pharmacies in Medicaid Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues relating to pharmacy benefit managers;; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act; H.R.4317 PBM Reform Act of 2025
Protecting Pharmacies in Medicaid Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues relating to pharmacy benefit managers;; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act; H.R.4317 PBM Reform Act of 2025
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues relating to pharmacy benefit managers; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S. CON. RES.__ Setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act.
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues relating to pharmacy benefit managers; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S. CON. RES.__ Setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act.
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues relating to pharmacy benefit managers; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S. CON. RES.__ Setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act.
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues relating to pharmacy benefit managers; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S. CON. RES.__ Setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act; H.R.4317 PBM Reform Act of 2025
Issues relating to pharmacy benefit managers; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S. CON. RES.__ Setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act.
Issues relating to pharmacy benefit managers; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S. CON. RES.__ Setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act; H.R.4317 PBM Reform Act of 2025
Issues relating to pharmacy benefit managers; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S. CON. RES.__ Setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act.
Issues relating to pharmacy benefit managers; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S. CON. RES.__ Setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act.
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
PBM Reform Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues relating to pharmacy benefit managers; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S. CON. RES.__ Setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act; H.R.4317 PBM Reform Act of 2025
PROTECT Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues relating to pharmacy benefit managers; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S. CON. RES.__ Setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act.
PROTECT Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues relating to pharmacy benefit managers; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S. CON. RES.__ Setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act.
PROTECT Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues relating to pharmacy benefit managers; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S. CON. RES.__ Setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act; H.R.4317 PBM Reform Act of 2025
PROTECT Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues relating to pharmacy benefit managers; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S. CON. RES.__ Setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act.
National Defense Authorization Act for Fiscal Year 2026
Client: CALIBER FINANCIAL SERVICES · Firm: EMERGENT STRATEGIES
S.2296 - National Defense Authorization Act for Fiscal Year 2026
National Defense Authorization Act for Fiscal Year 2026
Client: CALIBER FINANCIAL SERVICES · Firm: EMERGENT STRATEGIES
S.2296 - National Defense Authorization Act for Fiscal Year 2026
National Defense Authorization Act for Fiscal Year 2026
Client: CALIBER FINANCIAL SERVICES · Firm: EMERGENT STRATEGIES
S.2296 - National Defense Authorization Act for Fiscal Year 2026
Issues relating to pharmacy benefit managers; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S. CON. RES.__ Setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act.
Issues relating to pharmacy benefit managers; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S. CON. RES.__ Setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act.
Issues relating to pharmacy benefit managers; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S. CON. RES.__ Setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act.
Issues relating to pharmacy benefit managers; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S. CON. RES.__ Setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act; H.R.4317 PBM Reform Act of 2025
Protecting Pharmacies in Medicaid Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues relating to pharmacy benefit managers; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S. CON. RES.__ Setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act.
Protecting Pharmacies in Medicaid Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues relating to pharmacy benefit managers; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S. CON. RES.__ Setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act.
Protecting Pharmacies in Medicaid Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues relating to pharmacy benefit managers; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S. CON. RES.__ Setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act; H.R.4317 PBM Reform Act of 2025
Protecting Pharmacies in Medicaid Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues relating to pharmacy benefit managers; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S. CON. RES.__ Setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act.
American Relief Act, 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues related to pharmacy benefit managers; S.127 Pharmacy Benefit Manager Transparency Act of 2023; S.1339 Pharmacy Benefit Manager Reform Act; S.1542 DRUG Act; S.1979 Protecting Older Americans Act of 2023; H.R.5378 Lower Costs, More Transparency Act; H.R.7623 Telehealth Modernization Act of 2024; H.R.10545 American Relief Act, 2025.
Lower Costs, More Transparency Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues related to pharmacy benefit managers; S.127 Pharmacy Benefit Manager Transparency Act of 2023; S.1339 Pharmacy Benefit Manager Reform Act; S.1542 DRUG Act; S.1979 Protecting Older Americans Act of 2023; H.R.5378 Lower Costs, More Transparency Act; H.R.7623 Telehealth Modernization Act of 2024.
Lower Costs, More Transparency Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues related to pharmacy benefit managers; S.127 Pharmacy Benefit Manager Transparency Act of 2023; S.1339 Pharmacy Benefit Manager Reform Act; S.1542 DRUG Act; S.1979 Protecting Older Americans Act of 2023; H.R.5378 Lower Costs, More Transparency Act; H.R.7623 Telehealth Modernization Act of 2024; H.R.10545 American Relief Act, 2025.
Lower Costs, More Transparency Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues related to pharmacy benefit managers; S.127 Pharmacy Benefit Manager Transparency Act of 2023; S.1339 Pharmacy Benefit Manager Reform Act; S.1542 DRUG Act; S.1979 Protecting Older Americans Act of 2023; H.R.5378 Lower Costs, More Transparency Act; H.R.7623 Telehealth Modernization Act of 2024.
Telehealth Modernization Act of 2024
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues related to pharmacy benefit managers; S.127 Pharmacy Benefit Manager Transparency Act of 2023; S.1339 Pharmacy Benefit Manager Reform Act; S.1542 DRUG Act; S.1979 Protecting Older Americans Act of 2023; H.R.5378 Lower Costs, More Transparency Act; H.R.7623 Telehealth Modernization Act of 2024; H.R.10545 American Relief Act, 2025.
Telehealth Modernization Act of 2024
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues related to pharmacy benefit managers; S.127 Pharmacy Benefit Manager Transparency Act of 2023; S.1339 Pharmacy Benefit Manager Reform Act; S.1542 DRUG Act; S.1979 Protecting Older Americans Act of 2023; H.R.5378 Lower Costs, More Transparency Act; H.R.7623 Telehealth Modernization Act of 2024.
Telehealth Modernization Act of 2024
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues related to pharmacy benefit managers; S.127 Pharmacy Benefit Manager Transparency Act of 2023; S.1339 Pharmacy Benefit Manager Reform Act; S.1542 DRUG Act; S.1979 Protecting Older Americans Act of 2023; H.R.5378 Lower Costs, More Transparency Act; H.R.7623 Telehealth Modernization Act of 2024.
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues related to pharmacy benefit managers; S.127 Pharmacy Benefit Manager Transparency Act of 2023; S.1339 Pharmacy Benefit Manager Reform Act; S.1542 DRUG Act; S.1979 Protecting Older Americans Act of 2023; H.R.5378 Lower Costs, More Transparency Act; H.R.7623 Telehealth Modernization Act of 2024; H.R.10545 American Relief Act, 2025.
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues related to pharmacy benefit managers; S.127 Pharmacy Benefit Manager Transparency Act of 2023; S.1339 Pharmacy Benefit Manager Reform Act; S.1542 DRUG Act; S.1979 Protecting Older Americans Act of 2023; H.R.5378 Lower Costs, More Transparency Act; H.R.7623 Telehealth Modernization Act of 2024.
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues related to pharmacy benefit managers; S.127 Pharmacy Benefit Manager Transparency Act of 2023; S.1339 Pharmacy Benefit Manager Reform Act; S.1542 DRUG Act; S.1979 Protecting Older Americans Act of 2023; H.R.5378 Lower Costs, More Transparency Act; H.R.7623 Telehealth Modernization Act of 2024.
Pharmacy Benefit Manager Reform Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues related to pharmacy benefit managers; S.127 Pharmacy Benefit Manager Transparency Act of 2023; S.1339 Pharmacy Benefit Manager Reform Act; S.1542 DRUG Act; S.1979 Protecting Older Americans Act of 2023; H.R.5378 Lower Costs, More Transparency Act; H.R.7623 Telehealth Modernization Act of 2024.
Pharmacy Benefit Manager Reform Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues related to pharmacy benefit managers; S.127 Pharmacy Benefit Manager Transparency Act of 2023; S.1339 Pharmacy Benefit Manager Reform Act; S.1542 DRUG Act; S.1979 Protecting Older Americans Act of 2023; H.R.5378 Lower Costs, More Transparency Act; H.R.7623 Telehealth Modernization Act of 2024; H.R.10545 American Relief Act, 2025.
Pharmacy Benefit Manager Reform Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues related to pharmacy benefit managers; S.127 Pharmacy Benefit Manager Transparency Act of 2023; S.1339 Pharmacy Benefit Manager Reform Act; S.1542 DRUG Act; S.1979 Protecting Older Americans Act of 2023; H.R.5378 Lower Costs, More Transparency Act; H.R.7623 Telehealth Modernization Act of 2024.
Issues related to pharmacy benefit managers; S.127 Pharmacy Benefit Manager Transparency Act of 2023; S.1339 Pharmacy Benefit Manager Reform Act; S.1542 DRUG Act; S.1979 Protecting Older Americans Act of 2023; H.R.5378 Lower Costs, More Transparency Act; H.R.7623 Telehealth Modernization Act of 2024; H.R.10545 American Relief Act, 2025.
Issues related to pharmacy benefit managers; S.127 Pharmacy Benefit Manager Transparency Act of 2023; S.1339 Pharmacy Benefit Manager Reform Act; S.1542 DRUG Act; S.1979 Protecting Older Americans Act of 2023; H.R.5378 Lower Costs, More Transparency Act; H.R.7623 Telehealth Modernization Act of 2024.
Issues related to pharmacy benefit managers; S.127 Pharmacy Benefit Manager Transparency Act of 2023; S.1339 Pharmacy Benefit Manager Reform Act; S.1542 DRUG Act; S.1979 Protecting Older Americans Act of 2023; H.R.5378 Lower Costs, More Transparency Act; H.R.7623 Telehealth Modernization Act of 2024.
Protecting Older Americans Act of 2023
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues related to pharmacy benefit managers; S.127 Pharmacy Benefit Manager Transparency Act of 2023; S.1339 Pharmacy Benefit Manager Reform Act; S.1542 DRUG Act; S.1979 Protecting Older Americans Act of 2023; H.R.5378 Lower Costs, More Transparency Act; H.R.7623 Telehealth Modernization Act of 2024; H.R.10545 American Relief Act, 2025.
Protecting Older Americans Act of 2023
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues related to pharmacy benefit managers; S.127 Pharmacy Benefit Manager Transparency Act of 2023; S.1339 Pharmacy Benefit Manager Reform Act; S.1542 DRUG Act; S.1979 Protecting Older Americans Act of 2023; H.R.5378 Lower Costs, More Transparency Act; H.R.7623 Telehealth Modernization Act of 2024.
Protecting Older Americans Act of 2023
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: EMERGENT STRATEGIES
Issues related to pharmacy benefit managers; S.127 Pharmacy Benefit Manager Transparency Act of 2023; S.1339 Pharmacy Benefit Manager Reform Act; S.1542 DRUG Act; S.1979 Protecting Older Americans Act of 2023; H.R.5378 Lower Costs, More Transparency Act; H.R.7623 Telehealth Modernization Act of 2024.
2026 · third_quarter · Q3
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act S.4144, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via EMERGENT STRATEGIES
2026 · third_quarter · Q3
Issues relating to pharmacy benefit managers;; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act; H.R.4317 PBM Reform Act of 2025
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIFE360 via EMERGENT STRATEGIES
2026 · third_quarter · Q3
Issues related to competition in mobile app ecosystems; S.4746 American Innovation and Choice Online Act; S.2513 Open App Markets Act; H.R.3209 App Store Freedom Act
Issues related to competition in mobile app ecosystems; S.4746, American Innovation and Choice Online Act; S.2153, Open App Markets Act; H.R.3209, App Store Freedom Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CALIBER FINANCIAL SERVICES via EMERGENT STRATEGIES
2026 · third_quarter · Q3
Issues related to banking services for legal marijuana businesses by a depository institution
Issues related to National Defense Authorization Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via EMERGENT STRATEGIES
2026 · second_quarter · Q2
Issues relating to pharmacy benefit managers;; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act; H.R.4317 PBM Reform Act of 2025
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LEXINGTON LAW via EMERGENT STRATEGIES
2026 · second_quarter · Q2
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act S.4144, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
LIFE360 via EMERGENT STRATEGIES
2026 · second_quarter · Q2
Issues related to competition in mobile app ecosystems; S.4746, American Innovation and Choice Online Act; S.2153, Open App Markets Act; H.R.3209, App Store Freedom Act; H.R.8413, SECURE Data Act
Issues related to competition in mobile app ecosystems; S.4746 American Innovation and Choice Online Act; S.2513 Open App Markets Act; H.R.3209 App Store Freedom Act; H.R.8413 SECURE Data Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CREDIT.COM (FORMERLY KNOWN AS PROGREXION ASG) via EMERGENT STRATEGIES
2026 · second_quarter · Q2
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act S.4144, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
CALIBER FINANCIAL SERVICES via EMERGENT STRATEGIES
2026 · second_quarter · Q2
Issues related to banking services for legal marijuana businesses by a depository institution
Issues related to National Defense Authorization Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIFE360 via EMERGENT STRATEGIES
2026 · second_quarter · RA
Issues related to competition in mobile app ecosystems; S.__ American Innovation and Choice Online Act; S.2153 Open App Markets Act; H.R.3209 App Store Freedom Act
Issues related to competition in mobile app ecosystems; S.__ American Innovation and Choice Online Act; S.2153 Open App Markets Act; H.R.3209 App Store Freedom Act
LIFE360 via EMERGENT STRATEGIES
2026 · first_quarter · RR
Issues related to competition in mobile app ecosystems; S.__ American Innovation and Choice Online Act; S.2153 Open App Markets Act; H.R.3209 App Store Freedom Act
Issues related to competition in mobile app ecosystems; S.__ American Innovation and Choice Online Act; S.2153 Open App Markets Act; H.R.3209 App Store Freedom Act
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via EMERGENT STRATEGIES
2026 · first_quarter · Q1
Issues relating to pharmacy benefit managers;; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act; H.R.4317 PBM Reform Act of 2025
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CREDIT.COM (FORMERLY KNOWN AS PROGREXION ASG) via EMERGENT STRATEGIES
2026 · first_quarter · 1A
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act S.4144, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
LEXINGTON LAW via EMERGENT STRATEGIES
2026 · first_quarter · Q1
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act S.4144, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
CREDIT.COM (FORMERLY KNOWN AS PROGREXION ASG) via EMERGENT STRATEGIES
2026 · first_quarter · Q1
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act S.4144, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
CALIBER FINANCIAL SERVICES via EMERGENT STRATEGIES
2026 · first_quarter · Q1
Issues related to banking services for legal marijuana businesses by a depository institution
Issues related to National Defense Authorization Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LEXINGTON LAW via EMERGENT STRATEGIES
2025 · fourth_quarter · Q4
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via EMERGENT STRATEGIES
2025 · fourth_quarter · Q4
Issues relating to pharmacy benefit managers; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S. CON. RES.__ Setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act; H.R.4317 PBM Reform Act of 2025
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CREDIT.COM (FORMERLY KNOWN AS PROGREXION ASG) via EMERGENT STRATEGIES
2025 · fourth_quarter · Q4
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
CALIBER FINANCIAL SERVICES via EMERGENT STRATEGIES
2025 · fourth_quarter · Q4
Issues related to banking services for legal marijuana businesses by a depository institution
S.2296 - National Defense Authorization Act for Fiscal Year 2026
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via EMERGENT STRATEGIES
2025 · third_quarter · Q3
Issues relating to pharmacy benefit managers; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S. CON. RES.__ Setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LEXINGTON LAW via EMERGENT STRATEGIES
2025 · third_quarter · Q3
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
CREDIT.COM (FORMERLY KNOWN AS PROGREXION ASG) via EMERGENT STRATEGIES
2025 · third_quarter · Q3
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
CALIBER FINANCIAL SERVICES via EMERGENT STRATEGIES
2025 · third_quarter · Q3
Issues related to banking services for legal marijuana businesses by a depository institution
S.2296 - National Defense Authorization Act for Fiscal Year 2026
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CREDIT.COM (FORMERLY KNOWN AS PROGREXION ASG) via EMERGENT STRATEGIES
2025 · second_quarter · 2A
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
LEXINGTON LAW via EMERGENT STRATEGIES
2025 · second_quarter · Q2
Issues related to consumer credit report correction and the credit repair industry Issues pertaining to legislation to repeal FCRA 15 U.S.C. 1681s-2(a)(8)(G) exclusion provision H.R.306, Ending Scam Credit Repair Act Issues related to establishing a uniform regulatory approach to the Telemarketing Sales Rule's advance fee prohibition for the credit repair industry
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via EMERGENT STRATEGIES
2025 · second_quarter · Q2
Issues relating to pharmacy benefit managers; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S. CON. RES.__ Setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CALIBER FINANCIAL SERVICES via EMERGENT STRATEGIES
2025 · second_quarter · Q2
Issues related to banking services for legal marijuana businesses by a depository institution
S.2296 - National Defense Authorization Act for Fiscal Year 2026
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S&P GLOBAL INC. via EMERGENT STRATEGIES
2025 · first_quarter · 1T
Legislation and regulations affecting issuers of credit ratings and institutional investors; Issues generally related to ESG ratings and data regulatory frameworks (no specific legislation introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via EMERGENT STRATEGIES
2025 · first_quarter · Q1
Issues relating to pharmacy benefit managers; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S. CON. RES.__ Setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via EMERGENT STRATEGIES
2024 · fourth_quarter · Q4
Issues related to pharmacy benefit managers; S.127 Pharmacy Benefit Manager Transparency Act of 2023; S.1339 Pharmacy Benefit Manager Reform Act; S.1542 DRUG Act; S.1979 Protecting Older Americans Act of 2023; H.R.5378 Lower Costs, More Transparency Act; H.R.7623 Telehealth Modernization Act of 2024; H.R.10545 American Relief Act, 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S&P GLOBAL INC. via EMERGENT STRATEGIES
2024 · fourth_quarter · Q4
Legislation and regulations affecting issuers of credit ratings and institutional investors; issues generally related to ESG ratings and data regulatory frameworks (no specific legislation introduced or pending in 2024 Q4)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S&P GLOBAL INC. via EMERGENT STRATEGIES
2024 · third_quarter · Q3
Legislation and regulations affecting issuers of credit ratings and institutional investors; issues generally related to ESG ratings and data regulatory frameworks (no specific legislation introduced or pending in 2023 Q2)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via EMERGENT STRATEGIES
2024 · third_quarter · Q3
Issues related to pharmacy benefit managers; S.127 Pharmacy Benefit Manager Transparency Act of 2023; S.1339 Pharmacy Benefit Manager Reform Act; S.1542 DRUG Act; S.1979 Protecting Older Americans Act of 2023; H.R.5378 Lower Costs, More Transparency Act; H.R.7623 Telehealth Modernization Act of 2024.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S&P GLOBAL INC. via EMERGENT STRATEGIES
2024 · second_quarter · Q2
Legislation and regulations affecting issuers of credit ratings and institutional investors; issues generally related to ESG ratings and data regulatory frameworks (no specific legislation introduced or pending in 2023 Q2)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via EMERGENT STRATEGIES
2024 · second_quarter · Q2
Issues related to pharmacy benefit managers; S.127 Pharmacy Benefit Manager Transparency Act of 2023; S.1339 Pharmacy Benefit Manager Reform Act; S.1542 DRUG Act; S.1979 Protecting Older Americans Act of 2023; H.R.5378 Lower Costs, More Transparency Act; H.R.7623 Telehealth Modernization Act of 2024.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via EMERGENT STRATEGIES
2024 · second_quarter · RR
Issues relating to pharmacy benefit managers
S&P GLOBAL INC. via EMERGENT STRATEGIES
2024 · first_quarter · Q1
Legislation and regulations affecting issuers of credit ratings and institutional investors; issues generally related to ESG ratings and data regulatory frameworks (no specific legislation introduced or pending in 2023 Q2)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S&P GLOBAL INC. via EMERGENT STRATEGIES
2023 · fourth_quarter · Q4
Legislation and regulations affecting issuers of credit ratings and institutional investors; issues generally related to ESG ratings and data regulatory frameworks (no specific legislation introduced or pending in 2023 Q2)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of
S&P GLOBAL INC. via EMERGENT STRATEGIES
2023 · third_quarter · Q3
Legislation and regulations affecting issuers of credit ratings and institutional investors; issues generally related to ESG ratings and data regulatory frameworks (no specific legislation introduced or pending in 2023 Q2)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of
S&P GLOBAL INC. via EMERGENT STRATEGIES
2023 · second_quarter · Q2
Legislation and regulations affecting issuers of credit ratings and institutional investors; issues generally related to ESG ratings and data regulatory frameworks (no specific legislation introduced or pending in 2023 Q2)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of
S&P GLOBAL INC. via EMERGENT STRATEGIES
2023 · first_quarter · Q1
Legislation and regulations affecting issuers of credit ratings and institutional investors
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of
S&P GLOBAL INC. via EMERGENT STRATEGIES
2022 · fourth_quarter · Q4
Legislation and regulations affecting issuers of credit ratings and institutional investors
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of
S&P GLOBAL INC. via EMERGENT STRATEGIES
2022 · third_quarter · Q3
Legislation and regulations affecting issuers of credit ratings and institutional investors
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of
S&P GLOBAL INC. via EMERGENT STRATEGIES
2022 · second_quarter · Q2
Legislation and regulations affecting issuers of credit ratings and institutional investors
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of
S&P GLOBAL INC. via EMERGENT STRATEGIES
2022 · first_quarter · Q1
Legislation and regulations affecting issuers of credit ratings and institutional investors
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of
S&P GLOBAL INC. via EMERGENT STRATEGIES
2021 · fourth_quarter · Q4
Legislation and regulations affecting issuers of credit ratings and institutional investors
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of
S&P GLOBAL INC. via EMERGENT STRATEGIES
2021 · third_quarter · Q3
Legislation and regulations affecting issuers of credit ratings and institutional investors
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of
S&P GLOBAL INC. via EMERGENT STRATEGIES
2021 · second_quarter · Q2
Legislation and regulations affecting issuers of credit ratings and institutional investors
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of
S&P GLOBAL INC. via EMERGENT STRATEGIES
2021 · first_quarter · Q1
Legislation and regulations affecting issuers of credit ratings and institutional investors
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of
S&P GLOBAL INC. via EMERGENT STRATEGIES
2020 · fourth_quarter · Q4
Legislation and regulations affecting issuers of credit ratings and institutional investors CARES Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of
S&P GLOBAL INC. via EMERGENT STRATEGIES
2020 · third_quarter · Q3
Legislation and regulations affecting issuers of credit ratings and institutional investors CARES Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of
S&P GLOBAL INC. via EMERGENT STRATEGIES
2020 · second_quarter · Q2
Legislation and regulations affecting issuers of credit ratings and institutional investors CARES Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of
S&P GLOBAL INC. via EMERGENT STRATEGIES
2020 · first_quarter · Q1
Legislation and regulations affecting issuers of credit ratings and institutional investors CARES Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of
S&P GLOBAL INC. via EMERGENT STRATEGIES
2020 · first_quarter · RR
Legislation and regulations affecting issuers of credit ratings and institutional investors.